Login
From:
Lupus News Today
(Uncensored)
subscribe
Dapirolizumab pegol reduced SLE disease activity, fatigue: Trial
https://lupusnewstoday.com/news/dapirolizumab-pegol-reduced-sle-disease-activity-fatigue-trial/
links
backlinks
Tagged with:
news
fatigue
systemic lupus erythematous
One year of treatment with dapirolizumab pegol reduced fatigue and disease activity in people with SLE in a Phase 3 trial.
Roast topics
Find topics
Find it!
